Docusign (NASDAQ:DOCU) Price Target Raised to $70.00

Key Points

• UBS raised Docusign’s price target from $54 to $70 while maintaining a neutral rating, implying 6.68% upside. The broader analyst consensus remains “Hold,” with an average target of $64.33.
• Docusign reported quarterly results above expectations, with revenue up 9.4% year over year to $875.75 million and EPS of $1.16 versus the $1.09 consensus estimate.
• Shares opened at $65.62, with the company valued at approximately $12.53 billion; insiders sold 90,602 shares worth $4.32 million over the past three months, while institutional investors own 77.64% of the stock.

Docusign (NASDAQ:DOCU - Get Free Report) had its price target increased by analysts at UBS Group from $54.00 to $70.00 in a report released on Friday, Benzinga reports. The brokerage presently has a "neutral" rating on the stock. UBS Group's price objective suggests a potential upside of 6.68% from the stock's current price.

A number of other brokerages have also commented on DOCU. Robert W. Baird set a $72.00 target price on Docusign in a research note on Friday. Wells Fargo & Company set a $60.00 price target on shares of Docusign in a research note on Friday. Morgan Stanley reissued an "equal weight" rating and issued a $75.00 price target on shares of Docusign in a report on Friday. Piper Sandler reaffirmed a "neutral" rating and set a $75.00 price objective on shares of Docusign in a report on Friday. Finally, Bank of America reissued an "underperform" rating on shares of Docusign in a research note on Friday, August 28th. Three equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Docusign has a consensus rating of "Hold" and an average target price of $64.33.

Docusign Stock Down 0.5%

Shares of DOCU opened at $65.62 on Friday. Docusign has a 12-month low of $40.16 and a 12-month high of $86.65. The firm has a market capitalization of $12.53 billion, a price-to-earnings ratio of 42.47, a P/E/G ratio of 2.32 and a beta of 0.90. The stock's 50-day moving average price is $55.24 and its 200 day moving average price is $49.74.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping analysts' consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The company had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. During the same quarter last year, the company earned $0.30 EPS. The company's quarterly revenue was up 9.4% on a year-over-year basis. Equities research analysts expect that Docusign will post 2.03 EPS for the current year.

Insider Activity

In other news, Director James A. Beer sold 450 shares of the firm's stock in a transaction on Friday, August 28th. The stock was sold at an average price of $64.02, for a total value of $28,809.00. Following the completion of the sale, the director directly owned 14,586 shares in the company, valued at approximately $933,795.72. This trade represents a 2.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan C. Thygesen sold 26,250 shares of the company's stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $46.02, for a total transaction of $1,208,025.00. Following the transaction, the chief executive officer owned 159,038 shares in the company, valued at approximately $7,318,928.76. This trade represents a 14.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 90,602 shares of company stock worth $4,323,749. 0.59% of the stock is currently owned by insiders.

Institutional Trading of Docusign

Hedge funds have recently modified their holdings of the stock. Modus Advisors LLC acquired a new position in Docusign during the 4th quarter worth $27,000. Cary Street Partners Investment Advisory LLC increased its stake in shares of Docusign by 309.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company's stock valued at $38,000 after buying an additional 424 shares during the period. Basepoint Wealth LLC acquired a new stake in shares of Docusign in the 4th quarter valued at $39,000. Harbour Investments Inc. raised its position in shares of Docusign by 56.6% during the fourth quarter. Harbour Investments Inc. now owns 797 shares of the company's stock worth $55,000 after acquiring an additional 288 shares during the last quarter. Finally, CIBC Private Wealth Group LLC raised its position in shares of Docusign by 116.8% during the fourth quarter. CIBC Private Wealth Group LLC now owns 854 shares of the company's stock worth $58,000 after acquiring an additional 460 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Quarterly results beat expectations: Fiscal Q2 revenue rose 9.4% year over year to $875.7 million, exceeding the $867.2 million consensus estimate. Adjusted EPS of $1.16 also topped expectations of approximately $1.08–$1.09, compared with $0.92 a year earlier. Docusign Announces Second Quarter Fiscal 2027 Financial Results
• Positive Sentiment: Raised full-year outlook: Docusign increased fiscal 2027 guidance for revenue, annual recurring revenue (ARR), and IAM’s share of total ARR. Full-year revenue guidance of approximately $3.5 billion was broadly in line with consensus, while third-quarter revenue guidance of $886 million–$890 million was near analysts’ $888.2 million estimate. Docusign Raises Full-Year Forecast on AI Momentum
• Positive Sentiment: AI growth narrative is gaining traction: Management cited accelerating IAM adoption and AI-related demand as drivers of the improved outlook. Docusign also plans to make its Model Context Protocol server available to every AI agent on September 30, positioning its agreement technology as an infrastructure layer for enterprise AI workflows. Docusign Agreement Layer for the Agentic Enterprise Coming to Every Agent
• Positive Sentiment: Analyst price-target support: BTIG raised its Docusign price target to $75, while Morgan Stanley also boosted its target, adding to the bullish reaction following the earnings report. BTIG Boosts Docusign Price Target
• Neutral Sentiment: Mixed technical and analyst signals: DOCU has formed a bullish “golden cross” and trades well above its 200-day moving average, but Needham reaffirmed a “hold” rating, indicating that some analysts believe the recent rally may already reflect much of the improved outlook.

Docusign Company Profile

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source